Pancreatic Cancer

  • Andrew M. Lowy
  • Steven D. Leach
  • Philip A. Philip

Part of the M. D. Anderson Solid Tumor Oncology Series book series (MDA)

Table of contents

  1. Front Matter
    Pages i-xviii
  2. Molecular Pathology and Epidemiology

    1. N. Volkan Adsay, Duangpen Thirabanjasak, Deniz Altinel
      Pages 3-26
    2. Eric S. Calhoun, Scott E. Kern
      Pages 27-39
    3. Ralph H. Hruban, Kieran Brune, Noriyoshi Fukushima, Anirban Maitra
      Pages 41-51
    4. James G. Kench, Peter H. Cosman, Neil D. Merrett, Andrew V. Biankin
      Pages 53-64
    5. Kieran A. Brune, Alison P. Klein
      Pages 65-79
    6. Julia B. Greer, Narcis O. Zarnescu, David C. Whitcomb
      Pages 81-96
  3. Pancreatic Cancer Biology

    1. Solomon Afelik, Jan Jensen
      Pages 99-116
    2. L. Charles Murtaugh, Jared Cassiano, Jean-Paul De La O
      Pages 117-135
    3. Laleh G. Melstrom, Paul J. Grippo
      Pages 137-158
    4. Genevieve M. Boland, Sarah P. Thayer
      Pages 181-228
  4. Pancreatic Cancer Staging

    1. Haydee Ojeda-Fournier, K. Ann Choe
      Pages 255-270
    2. M. Fernandez-Ulloa
      Pages 271-283
    3. William R. Brugge
      Pages 285-294
    4. Matthew H. Katz, Abdool R. Moossa, Michael Bouvet
      Pages 295-310
  5. Surgery for Pancreatic Cancer

    1. L. Andrew Shirley, Charles J. Yeo
      Pages 313-327
    2. Thomas Schnelldorfer, Kaye M. Reid Lombardo, Michael B. Farnell, Michael G. Sarr
      Pages 329-339
    3. Andrew S. Resnick, Jeffrey A. Drebin
      Pages 341-350

About this book

Introduction

Since the first M. D. Anderson Solid Tumor Oncology Series volume on pancreatic cancer, there have been major advances in our understanding of molecular events which underlie pancreatic cancer development, both in the sporadic and inherited forms. We have seen the development of the first mouse models that accurately recapitulate features of the human disease. Several landmark clinical trials in both resectable and metastatic pancreatic cancer have been completed, raising new questions about the standard of care in this disease.

Finally, the era of targeted biologic therapies has engendered new excitement about the prospects of more rapid progress in understanding and successfully treating this dreadful disease. Therefore, it is an appropriate time to review these important advances and outline areas of controversy and question in pancreatic cancer biology and treatment.

Keywords

Staging angiogenesis carcinoma endoscopy imaging surgery

Editors and affiliations

  • Andrew M. Lowy
    • 1
  • Steven D. Leach
    • 2
  • Philip A. Philip
    • 3
  1. 1.University of California San DiegoLa JollaUSA
  2. 2.School of MedicineJohns Hopkins UniversityBaltimoreUSA
  3. 3.Wayne State UniversityDetroitUSA

Bibliographic information

  • DOI https://doi.org/10.1007/978-0-387-69252-4
  • Copyright Information Springer-Verlag US 2008
  • Publisher Name Springer, Boston, MA
  • eBook Packages Medicine
  • Print ISBN 978-0-387-69250-0
  • Online ISBN 978-0-387-69252-4
  • About this book